ICD-10 Coding for Vulvovaginal Candidiasis(A59.01, A59.01U, B37.3)
Explore ICD-10 coding for vulvovaginal candidiasis, including acute (B37.31) and chronic (B37.32) cases. Learn documentation requirements and coding tips.
Complete code families applicable to Vulvovaginal Candidiasis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| B37.31 | Acute candidiasis of vulva and vagina | Use when the patient presents with acute symptoms of vulvovaginal candidiasis, confirmed by laboratory tests. |
|
| B37.32 | Chronic candidiasis of vulva and vagina | Use for chronic or recurrent cases, particularly when symptoms persist despite treatment. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutVulvovaginal Candidiasis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Vulvovaginal Candidiasis.
Documenting 'yeast infection' without specifying location or acuity.
Impact
Clinical: May lead to incorrect treatment., Regulatory: Fails to meet documentation standards., Financial: Could result in claim denials.
Mitigation
Educate providers on documentation requirements, Use templates that prompt for specific details
Using B37.9 (unspecified) when acuity is documented.
Impact
Reimbursement: May lead to denials due to lack of specificity., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health records.
Mitigation
Query provider to specify acute or chronic candidiasis.
Use of unspecified codes
Impact
High risk of audit if unspecified codes are used when specificity is documented.
Mitigation
Ensure documentation supports the most specific code available.